Filing Flows › Retractable Technologies (RVP) › Blood Collection Products revenue
Retractable Technologies (RVP) Blood Collection Products revenue by quarter
Retractable Technologies' Blood Collection Products revenue was $296K in Q2 2026 (second quarter 2026), -21% from Q1 2026. Over the last 7 quarters it ranged from $282K (Q4 2024) to $375K (Q1 2026).
| Quarter | Blood Collection Products revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $296K | -21% | -2% |
| Q1 2026 | $375K | +7% | +9% |
| Q4 2025 | $351K | -6% | +24% |
| Q3 2025 | $373K | +23% | — |
| Q2 2025 | $303K | -12% | — |
| Q1 2025 | $344K | +22% | — |
| Q4 2024 | $282K | — | — |
Q2 2026 at a glance
Retractable Technologies, Q2 2026: revenue $7.2M (-31% year over year), operating margin -71.5%, net earnings $2.8M, operating cash flow −$1.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is Retractable Technologies' Blood Collection Products revenue?
Retractable Technologies' Blood Collection Products revenue was $296K in Q2 2026 (second quarter 2026), -21% from Q1 2026.
How has Retractable Technologies' Blood Collection Products revenue changed?
Over the last 7 quarters it ranged from $282K (Q4 2024) to $375K (Q1 2026).
Q2 2026 results → · How Retractable Technologies makes money →